trans-Tranilast

CAS: 70806-55-2

Ref. 3D-FT28370

Información del producto

• Nombre: trans-Tranilast
• Sinónimos: 2-[[(2E)-3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic acid(E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzo ic Acid

Descripción

Trans-Tranilast is a drug that is being investigated for the treatment of inflammatory diseases. It is an experimental drug that has shown potential to reduce atherosclerotic lesions in animal models. Trans-Tranilast inhibits the formation of cell factors, which are compounds that are needed for many cellular processes, including protein synthesis and cell division. In addition, this drug has been shown to inhibit cyclic nucleotide phosphodiesterases and MMP-9 activity in vitro. Trans-Tranilast also prevents balloon injury in mice by reducing the production of growth factor β1 (GF-β1). Trans-Tranilast has a number of mechanisms of action, which may make it an effective treatment for inflammatory diseases.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 327.33 g/mol
• Fórmula: C₁₈H₁₇NO₅
• Pureza: Min. 95%
• InChI: InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+
• Clave InChI: InChIKey=NZHGWWWHIYHZNX-CSKARUKUSA-N
• SMILES: COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC